Related Experiment Video
Updated: Aug 8, 2025
12:38
Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells
Published on: November 6, 2021
2.6K
The structure, function, and pharmacology of MRGPRs
1Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Trends in Pharmacological Sciences
|March 4, 2023
Summary
Mas-related G protein-coupled receptors (MRGPRs) are key targets for treating itch and pain. Recent structural insights and new ligands offer opportunities for developing novel MRGPR-based therapeutics.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- Mas-related G protein-coupled receptors (MRGPRs) are crucial for sensing pain and itch.
- This receptor family exhibits diverse agonist recognition, complex signaling, and significant interspecies sequence variation.
- Human MRGPRs possess numerous polymorphisms, influencing drug interactions and therapeutic outcomes.
Purpose of the Study:
- To review recent advancements in understanding MRGPR structure and function.
- To explore the potential of MRGPRs as therapeutic targets for pain and itch conditions.
- To identify challenges and opportunities in structure-based drug discovery for MRGPRs.
Main Methods:
- Review of recent structural biology studies on MRGPRs.
- Analysis of newly discovered MRGPR ligands and their functional implications.
- Discussion of sequence diversity and human polymorphisms within the MRGPR family.
Main Results:
- Recent structural studies reveal unique features and diverse ligand-binding modes of MRGPRs.
- Newly identified ligands serve as valuable tools for functional exploration of MRGPRs.
- Understanding MRGPRs' structural and functional complexity aids in structure-based drug design.
Conclusions:
- Advances in MRGPR structural biology facilitate structure-based drug discovery.
- Novel ligands and structural insights enhance the therapeutic potential of targeting MRGPRs for itch and pain.
- Further research into MRGPRs presents significant opportunities for developing new analgesics and antipruritics.
Related Concept Videos
01:15G Protein-coupled Receptors
12.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.5K
01:30Transducer Mechanism: G Protein–Coupled Receptors
2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.1K
01:25Cholinergic Receptors: Muscarinic
2.6K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.6K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.8K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
01:12GPCR Desensitization
6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
01:22Opioid Receptors: Overview
1.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.3K